Perosphere Technologies and M3 Medical Sign Distribution Agreement for Perosphere ClotChek™ Point-of-Care Coagulometer in Ireland
11 Julio 2024 - 6:00AM
Business Wire
Ireland to be First Market for Perosphere’s
Novel Coagulation Diagnostic Tool
US-based Perosphere (Perosphere Technologies Inc.), a private
medical technologies company, today announced that it has signed an
agreement with M3 Medical, a Uniphar Medtech business and a leading
Irish medical device distributor, for the exclusive distribution of
Perosphere’s innovative Point-of-Care (PoC) Coagulometer,
Perosphere ClotChek™, in Ireland.
With this agreement, Ireland will be the first country in which
Perosphere ClotChek will become available to hospitals and health
facilities.
Many patients require anticoagulants, which help prevent blood
clots and stroke. Perosphere ClotChek is the only pharmacodynamic,
reagent-free diagnostic tool for use at the point-of-care, i.e.,
bedside. ClotChek test results can assist doctors and other health
care professionals (HCP) in the rapid diagnosis of coagulation
status and enabling informed treatment decision-making in emergency
and other medical settings. Perosphere ClotChek provides HCPs with
diagnostic results in 3-8 minutes.
Perosphere ClotChek has a CE Mark in the European Union.
“We are excited to partner with M3 Medical based on the
company’s longstanding expertise and demonstrated success in the
medical device market to improve patient care,” said Daryl Mootoo,
Chief Operating Officer of Perosphere. “We trust in M3 Medical’s
capabilities to bring Perosphere ClotChek to healthcare providers
in Ireland and help us change the current standard of testing and
care in anticoagulation management.”
“When searching for a distributor for Ireland, in addition to
operational excellence, we also wanted a partner with a
well-established team,” said David Walker, Vice President of
European Sales of Perosphere. “M3 Medical, now part of Uniphar
Medtech, has deep relationships with clinicians, hospitals, and
clinic decision-makers, making them an ideal partner.”
M3 Medical is a leading medical device distributor for
interventional cardiology, radiology, neuroradiology, and vascular
surgery in Ireland and the United Kingdom. M3 Medical is part of
Uniphar Medtech, a European medical device distributor
headquartered in Ireland with a strong presence across 21
markets.
“We recognize the value of Perosphere ClotChek, a unique
coagulation testing device, especially in Ireland given the
widespread use of anticoagulants and the unmet need for fast and
complete coagulation diagnosis,” adds Robbie Dolan, Business Unit
Leader – Ireland of M3 Medical. Mr. Dolan added, “We are proud to
enter into this exclusive agreement in order to help improve
patient outcomes and reduce health system costs in Ireland.”
About Perosphere Technologies
Perosphere Technologies is changing the way decisions are made
at the point-of-care in hospitals and outpatient clinics for
patients at risk for bleeding. A private medical technologies
company, Perosphere is focused on development and commercialization
of Perosphere ClotChek™, a novel PoC (point-of-care) Coagulometer,
which quickly informs diagnosis, treatment, and prevention
decisions through precision data, made immediately accessible to
all. It is the only PoC diagnostic tool that effectively and
swiftly tests clotting times across drug classes, including the
Direct Oral Anticoagulants (DOACs) and Novel Oral Anticoagulants
(NOACs). Perosphere ClotChek serves to help establish a new
standard of care for patients on anticoagulant therapies or at risk
for bleeding, and has the potential to improve efficiency, provide
significant cost savings, and support better patient outcomes.
Perosphere ClotChek has a CE Mark in the European Union and is not
FDA cleared in the United States.
For further information, contact us at info@perospheretech.com
or +1 (475) 218-4600.
www.perospheretech.com
About M3 Medical
M3 Medical is a premier distributor of cutting-edge medical
devices, specializing in interventional cardiology, radiology,
neuroradiology, vascular surgery, and cardiac rhythm management.
Our expertise lies in identifying and introducing innovative
technologies to healthcare professionals across Ireland and the
United Kingdom.
Our team's commitment to excellence is evident in our passion,
dedication, and deep market knowledge. We pride ourselves on
fostering strong customer relationships and delivering unparalleled
service, ensuring optimal device efficiency for healthcare
providers and improved patient outcomes.
As part of Uniphar Medtech, a leading European medical device
distributor with a presence in 21 markets, M3 Medical leverages an
extensive support network. This strategic alliance enhances our
ability to serve our distributors and partners, providing them with
comprehensive resources and expertise across diverse healthcare
landscapes.
For further information contact us at www.m3.ie or +353 1
5568800.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240711627342/en/
Gerard O'Shea FINN Partners gerard.oshea@finnpartners.com +353
87 413 7471